SciVision Biotech (Taiwan) Probability of Future Stock Price Finishing Over 77.7

1786 Stock  TWD 94.70  0.40  0.42%   
SciVision Biotech's future price is the expected price of SciVision Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of SciVision Biotech performance during a given time horizon utilizing its historical volatility. Check out SciVision Biotech Backtesting, SciVision Biotech Valuation, SciVision Biotech Correlation, SciVision Biotech Hype Analysis, SciVision Biotech Volatility, SciVision Biotech History as well as SciVision Biotech Performance.
  
Please specify SciVision Biotech's target price for which you would like SciVision Biotech odds to be computed.

SciVision Biotech Target Price Odds to finish over 77.7

The tendency of SciVision Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above NT$ 77.70  in 90 days
 94.70 90 days 77.70 
about 97.0
Based on a normal probability distribution, the odds of SciVision Biotech to stay above NT$ 77.70  in 90 days from now is about 97.0 (This SciVision Biotech probability density function shows the probability of SciVision Stock to fall within a particular range of prices over 90 days) . Probability of SciVision Biotech price to stay between NT$ 77.70  and its current price of NT$94.7 at the end of the 90-day period is about 22.05 .
Assuming the 90 days trading horizon SciVision Biotech has a beta of -0.32. This suggests as returns on the benchmark increase, returns on holding SciVision Biotech are expected to decrease at a much lower rate. During a bear market, however, SciVision Biotech is likely to outperform the market. Additionally SciVision Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   SciVision Biotech Price Density   
       Price  

Predictive Modules for SciVision Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SciVision Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
91.9194.3096.69
Details
Intrinsic
Valuation
LowRealHigh
83.5685.95103.73
Details

SciVision Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. SciVision Biotech is not an exception. The market had few large corrections towards the SciVision Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold SciVision Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of SciVision Biotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.45
β
Beta against Dow Jones-0.32
σ
Overall volatility
13.61
Ir
Information ratio -0.21

SciVision Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SciVision Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SciVision Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
SciVision Biotech generated a negative expected return over the last 90 days
About 38.0% of the company shares are owned by insiders or employees

SciVision Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of SciVision Stock often depends not only on the future outlook of the current and potential SciVision Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SciVision Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding66.2 M

SciVision Biotech Technical Analysis

SciVision Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. SciVision Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of SciVision Biotech. In general, you should focus on analyzing SciVision Stock price patterns and their correlations with different microeconomic environments and drivers.

SciVision Biotech Predictive Forecast Models

SciVision Biotech's time-series forecasting models is one of many SciVision Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary SciVision Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about SciVision Biotech

Checking the ongoing alerts about SciVision Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for SciVision Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
SciVision Biotech generated a negative expected return over the last 90 days
About 38.0% of the company shares are owned by insiders or employees

Additional Tools for SciVision Stock Analysis

When running SciVision Biotech's price analysis, check to measure SciVision Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SciVision Biotech is operating at the current time. Most of SciVision Biotech's value examination focuses on studying past and present price action to predict the probability of SciVision Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SciVision Biotech's price. Additionally, you may evaluate how the addition of SciVision Biotech to your portfolios can decrease your overall portfolio volatility.